Page 32 - Evelop News Today

Insulation materials and paints manufacturer Sto reported lower sales in the first quarter due to bad weather. The gross profit margin also did not develop as well as hoped, even though it improved... | May 10, 2023

LEVERKUSEN (dpa-AFX) - Bayer AG (BAYZF.PK) and Bicycle Therapeutics plc (BCYC) Wednesday announced partnership to develop Bicycle radioconjugates for multiple oncology targets.As per the deal,

Hässleholm 10 May 2023 Eolus has signed a cooperation agreement with Finnish landowner Finsilva for development of five wind power projects with a potential for more than 600 MW in total. The projects

A researcher at the University of Central Florida College of Medicine has created a novel, more accurate therapy for a leading source of sickness worldwide each year - acute respiratory virus infections.

NC3Rs has awarded £90K for two collaborative projects focused on cell-based models of disease for functional genomic screens that can be applied more confidently in industry to identify and validate potential new therapeutic targets. Click to read more...

By Joe Hoppe Capital Metals PLC shares soared Tuesday after it said it has signed an offtake agreement with LB Group Co., forming a 50/50 joint venture to develop and operate the Eastern... | May 9, 2023

Singapore, 9th May 2023 - Hong Leong Finance collaborates with Housing Development Board to develop the new project Integrated Housing Loan Application Service. The new... | May 9, 2023

Companies to explore converting an Indorama Ventures’ U.S. facility into bio-based materials plant to develop and commercialize low-carbon bio-based materials Companies to produce samples for... | May 9, 2023

Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that its wholly owned subsidiary, Redwire Space NV, has been awarded a 14 million

WARMINSTER, Pa., May 09, 2023 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target... | May 9, 2023